Clinical Trial Update: Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the Litx BPH System for lower urinary tract symptoms associated with benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Litx BPH System

Snippet

Sponsor: Light Sciences Oncology | Conditions: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms | Phase 1 | Status: COMPLETED